VTS-105

N/A

Report date: 2026/03/19 17:11:48

Base Information

Drug NameVTS-105

Drug Alias NameVTS105

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Trispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-BCMAAnti-GPRC5DCD3 T-cell engagers

TargetsB-cell maturation proteinG-protein coupled receptor family C group 5member DT cell surface glycoprotein CD3

Therapy Area/IndicationsAutoimmune DiseasesHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesVelaVigo (Hong Kong) Ltd

China Registration ClassN/A

Develop Information

Active CompaniesVelaVigo (Hong Kong) Ltd

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A